ATE412674T1 - Komplex aus chaperonin und targetprotein, verfahren zu dessen herstellung, verfahren zur stabilisierung des targetproteins, verfahren zur immobilisierung des targetproteins, verfahren zur analyse der struktur des targetproteins, zubereitung mit retardierter freisetzung und verfahren zur herstellung von antikörpern gegen das targetprotein - Google Patents

Komplex aus chaperonin und targetprotein, verfahren zu dessen herstellung, verfahren zur stabilisierung des targetproteins, verfahren zur immobilisierung des targetproteins, verfahren zur analyse der struktur des targetproteins, zubereitung mit retardierter freisetzung und verfahren zur herstellung von antikörpern gegen das targetprotein

Info

Publication number
ATE412674T1
ATE412674T1 AT04730054T AT04730054T ATE412674T1 AT E412674 T1 ATE412674 T1 AT E412674T1 AT 04730054 T AT04730054 T AT 04730054T AT 04730054 T AT04730054 T AT 04730054T AT E412674 T1 ATE412674 T1 AT E412674T1
Authority
AT
Austria
Prior art keywords
target protein
chaperonin
producing
complex
immobilizing
Prior art date
Application number
AT04730054T
Other languages
English (en)
Inventor
Akira Ideno
Jun-Ichi Hata
Akiko Togi
Masahiro Furutani
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Application granted granted Critical
Publication of ATE412674T1 publication Critical patent/ATE412674T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
AT04730054T 2003-04-28 2004-04-28 Komplex aus chaperonin und targetprotein, verfahren zu dessen herstellung, verfahren zur stabilisierung des targetproteins, verfahren zur immobilisierung des targetproteins, verfahren zur analyse der struktur des targetproteins, zubereitung mit retardierter freisetzung und verfahren zur herstellung von antikörpern gegen das targetprotein ATE412674T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003124352 2003-04-28

Publications (1)

Publication Number Publication Date
ATE412674T1 true ATE412674T1 (de) 2008-11-15

Family

ID=33410161

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04730054T ATE412674T1 (de) 2003-04-28 2004-04-28 Komplex aus chaperonin und targetprotein, verfahren zu dessen herstellung, verfahren zur stabilisierung des targetproteins, verfahren zur immobilisierung des targetproteins, verfahren zur analyse der struktur des targetproteins, zubereitung mit retardierter freisetzung und verfahren zur herstellung von antikörpern gegen das targetprotein

Country Status (9)

Country Link
US (1) US20070059794A1 (de)
EP (1) EP1619208B1 (de)
JP (1) JPWO2004096859A1 (de)
AT (1) ATE412674T1 (de)
AU (1) AU2004234282B2 (de)
CA (1) CA2522263A1 (de)
DE (1) DE602004017447D1 (de)
ES (1) ES2312997T3 (de)
WO (1) WO2004096859A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2583361C (en) * 2004-10-15 2015-08-04 Sekisui Chemical Co., Ltd. Gene immunization using an antigen-chaperonin fusion
JP2010159218A (ja) * 2009-01-07 2010-07-22 Sekisui Chem Co Ltd 融合タンパク質、タンパク質複合体、並びに、目的タンパク質の構造解析方法
JP2010235492A (ja) * 2009-03-31 2010-10-21 Sekisui Chem Co Ltd シャペロニン−目的タンパク質複合体及びその製造方法
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
JP6017422B2 (ja) 2010-08-10 2016-11-02 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ(ウペエフエル)Ecole Polytechnique Federale de Lausanne (EPFL) 赤血球結合療法
US20150094216A1 (en) * 2012-02-27 2015-04-02 The University Of Kansas Systems and methods for identifying protein stabilizers
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
KR20240154672A (ko) 2014-02-21 2024-10-25 에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) 글리코타겟팅 치료제
EP3638296A1 (de) 2017-06-16 2020-04-22 The University Of Chicago Zusammensetzungen und verfahren zur herbeiführung einer immuntoleranz
SG11202011078VA (en) 2018-05-09 2020-12-30 Univ Chicago Compositions and methods concerning immune tolerance

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU724399B2 (en) * 1995-08-18 2000-09-21 Sloan-Kettering Institute For Cancer Research Heat shock protein-based vaccines and immunotherapies
ES2439014T3 (es) * 1998-02-20 2014-01-21 The University Of Miami Complejo de péptido antigénico-proteína de choque térmico modificada
GB9913437D0 (en) * 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
EP1284986A4 (de) * 2000-04-17 2005-08-24 James E Rothman Komplexierung von protein-antigenen und hitzeschockproteinen mittels javelin
JP4038555B2 (ja) * 2000-12-26 2008-01-30 積水化学工業株式会社 組み換え蛋白質の生産方法及び融合蛋白質

Also Published As

Publication number Publication date
AU2004234282A1 (en) 2004-11-11
DE602004017447D1 (de) 2008-12-11
EP1619208A4 (de) 2006-07-12
EP1619208B1 (de) 2008-10-29
US20070059794A1 (en) 2007-03-15
WO2004096859A1 (ja) 2004-11-11
EP1619208A1 (de) 2006-01-25
CA2522263A1 (en) 2004-11-11
JPWO2004096859A1 (ja) 2006-07-13
AU2004234282B2 (en) 2008-02-07
ES2312997T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
DE602004017447D1 (de) Komplex aus chaperonin und targetprotein, verfahren zu dessen herstellung, verfahren zur stabilisierung des targetproteins, verfahren zur immobilisierung des targetproteins, verfahren zur analyse der struktur des targetproteins, zubereitung mit retardierter freisetzung und verfahren zur herstellung von antikörpern gegen das targetprotein
WO2004005477A3 (en) Protein microarrays on mirrored surfaces for performing proteomic analyses
NO2010021I1 (no) Denosumab
ATE393169T1 (de) Il-7-fusionsproteine mit antikörperportionen, deren herstellung und deren verwendung
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
DK1322960T3 (da) Allergen-mikroarrayassay
EA200600344A1 (ru) Антитела против vegf
DK1906928T3 (da) Kerner og mikrokapsler egnet til parenteral administration og fremgangsmåder til fremstilling deraf
EP2031063A3 (de) Modulatoren von Duftrezeptoren
Iwaki et al. Cargo-binding makes a wild-type single-headed myosin-VI move processively
ATE430198T1 (de) Antikörperkonstruktion unter verwendung einer mrl/lpr-maus
HUP0203537A2 (hu) Célmolekula transzgénikus állatban történő előállítására és tisztítására szolgáló eljárások
GEP20094629B (en) Nogo receptor binding protein
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
ATE366746T1 (de) Gegen das semp1-protein gerichtete antikörper, verfahren zu deren herstellung, und deren anwendungen
WO2020220044A3 (en) Self-assembling protein nanocage decorated with antibodies (sapna) and parts thereof
WO2005007198A3 (en) Design of disease specific agents for diagnostics and therapeutics based on the protein isoform of vegf, her-2, psa
ATE326984T1 (de) Verfahren zur verbindung von molekularen substanzen
FR2892820B1 (fr) Procede magnetique d'immunodiagnostic pour la mise en evidence de complexe anticorps/antigene, en particulier de groupe sanguin
DK2020604T3 (da) Ligand for den G-proteinkoblede receptor FPRL2
BG106021A (bg) Метод за диагностика на трансмисивни спонгиозни енцефалопатии
WO2006017181A3 (en) Methods and systems for predicting protein-ligand coupling specificities
Anderson et al. Integrating single domain antibodies into field-deployable rapid assays
JP2017508444A (ja) タンパク質コートされたポリマー性基材
Liao et al. Small-molecule arrays for sorting G-protein-coupled receptors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties